
Nitrosoglutathione
CAS No. 57564-91-7
Nitrosoglutathione( GSNO | SNOG | S-Nitrosoglutathione | Glutathione thionitrite )
Catalog No. M27194 CAS No. 57564-91-7
GSNO is an endogenous transnitrosation donor involved in S-nitrosation of a variety of cellular proteins. GSNO, an exogenous NO donor and substrate of rat alcohol dehydrogenase class III isoenzyme, inhibits cerebral angiotensin II-dependent and -independent AT1 receptor responses.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 43 | Get Quote |
![]() ![]() |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameNitrosoglutathione
-
NoteResearch use only, not for human use.
-
Brief DescriptionGSNO is an endogenous transnitrosation donor involved in S-nitrosation of a variety of cellular proteins. GSNO, an exogenous NO donor and substrate of rat alcohol dehydrogenase class III isoenzyme, inhibits cerebral angiotensin II-dependent and -independent AT1 receptor responses.
-
DescriptionGSNO is an endogenous transnitrosation donor involved in S-nitrosation of a variety of cellular proteins. GSNO, an exogenous NO donor and substrate of rat alcohol dehydrogenase class III isoenzyme, inhibits cerebral angiotensin II-dependent and -independent AT1 receptor responses.(In Vitro):GSNO completely abolished the AngII-dependent AT1 receptor-mediated vasoconstriction of cerebral arteries. GSNO had no impact on responses to other vasoconstrictors sharing (phenylephrine, U46619) or not (5-HT) the same signalling pathway. (In Vivo):Elevated blood pressure, proteinuria, and intrauterine growth restriction associated with PE were induced in Sprague-Dawley rats using L-NAME. These were partially reversed with the use of GSNO.
-
In VitroNitrosoglutathione (GSNO, 250 μM) prevents 90% of the response to 0.1 μM 5-HT and 40% of the response to 1.0 μM 5-HT in rings treated with LY-83583, indicating an effect of GSNO that was independent of guanylate cyclase activity.
-
In VivoNitrosoglutathione (GSNO, 8 mg/kg) significantly decreases systolic, diastolic, and mean arterial pressures in PE-induced rats from day 14 through day 20.Nitrosoglutathione (GSNO, 0.2 and 0.6 mg/kg) significantly inhibits superoxide production and suppressed NF-κB activation, iNOS induction, and 3-nitrotyrosine expression, but up-regulates endothelial NOS expression in the flap vessels. Animal Model:Male Lewis rats.Dosage:0.2 and 0.6 mg/kg.Administration:Slow intravenous injection via the opposite femoral vein into each rat.Result:Animals treated with 0.2 mg of GSNO per kilogram before reperfusion had an intermediate survival rate (40.2 ± 4.9%). Although 0.6 mg/kg of GSNO showed a better rescuing effect than 150 mg/kg of NAC, there was no significant difference between the groups.
-
SynonymsGSNO | SNOG | S-Nitrosoglutathione | Glutathione thionitrite
-
PathwayEndocrinology/Hormones
-
TargetRAAS
-
RecptorPI3Kδ
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number57564-91-7
-
Formula Weight336.32
-
Molecular FormulaC10H16N4O7S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 25 mg/mL (74.33 mM)
-
SMILESN[C@@H](CCC(=O)N[C@@H](CSN=O)C(=O)NCC(O)=O)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Daniel P. Gold, et al. Combination therapy. WO2019183226A1.
molnova catalog



related products
-
Theasinensin C
Theasinensin C is a compound extracted from black tea water with an IC50 value of 40.21 μM for renin activity.
-
Telmisartan
Telmisartan is an angiotensin II receptor antagonist (ARB) used in the management of hypertension.
-
Plantainoside D
Plantainoside D shows potent antioxidative effects as those of ascorbic acid it shows angiotensin-converting enzyme (ACE) inhibitory inhibitory activity in vitro with the IC(50) value of 2.17 mM it also shows inhibitory activity against PKCalpha with the IC50 value14.8microM.?